Wickliffe-based Lubrizol Corp. has acquired Bavaria Medizin Technologie GmbH in Germany.
Bavaria Medizin Technologie makes intravascular and nonvascular devices like drug-coated balloons, according to a news release. The company offers original equipment manufacturing services and private label manufacturing of proprietary catheters and balloons. It’s headquartered near Munich, Germany, and also has a manufacturing site in Sibiu, Romania. It has more than 100 employees.
Lubrizol has about 8,700 employees across the globe and had $6.8 billion in revenues in 2018.
The acquisition was made by Lubrizol’s German subsidiary Lubrizol Deutschland GmbH. It purchased Bavaria Medizin Technologie from majority shareholder Custos Vermögensverwaltungs GmbH and minority shareholders, the release stated. Terms of the acquisition are not being disclosed.
By Rachel Abbey McCafferty
Source: Crain’s Cleveland Business
INEOS Inovyn announces a new Ultra Low Carbon range (ULC) of Chlor-Alkali products that reduce the carbon footprint of caustic soda, caustic potash and chlorine by up to 70% compared to industry averages. The new range uses renewable energy sources to power INEOS Inovyn manufacturing sites.
Solvay operates seven soda ash plants worldwide. Beyond Green River, coal is being phased out at two of the company’s plants in France and Germany. By the end of 2024, the Rheinberg, Germany site will become the first soda ash plant in the world to be powered primarily with renewable energy.
The Chemours Company has named Pamela Fletcher to its board of directors, effective March 1. Fletcher, formerly the chief sustainability officer at Delta Air Lines Inc., takes the seat of Sandra Phillips Rogers, who has opted not to stand for reelection to the company’s board.